share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Rice Derica W

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施贵宝 | 4：持股变动声明
SEC announcement ·  04/02 18:46
Moomoo AI 已提取核心信息
Derica W. Rice, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on March 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Rice to the issuer was also not specified. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Derica W. Rice, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on March 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Rice to the issuer was also not specified. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
百时美施贵宝（BMY）的举报人德里卡·赖斯于2024年3月31日参与了该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。赖斯与发行人的关系也没有具体说明。建议投资者寻求更多信息，以充分了解该事件对其投资决策的影响。
百时美施贵宝（BMY）的举报人德里卡·赖斯于2024年3月31日参与了该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。赖斯与发行人的关系也没有具体说明。建议投资者寻求更多信息，以充分了解该事件对其投资决策的影响。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息